The Jülich Supercomputing Centre announced in February 2025, that it is permanently incorporating the U.S.-based D-Wave annealing quantum computer after three years of successful hosting and usage.
Innoviva Specialty Therapeutics, a subsidiary of Innoviva Inc., today announced that its infectious disease therapeutic portfolio earned a strong performance rating of 80% in the 2026 Antimicrobial ...